Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Lawrence Berger, M.D.

Co-Author

This page shows the publications co-authored by David Berger and Naomi Sell.
Connection Strength

1.480
  1. The time Interval Between the End of Radiotherapy and Surgery Does Not Affect Outcomes in Rectal Cancer. Am Surg. 2021 Oct 11; 31348211047215.
    View in: PubMed
    Score: 0.248
  2. Prognosis of Different Histological Types in Patients with Stage II and III Colon Cancer. J Gastrointest Surg. 2021 Sep 09.
    View in: PubMed
    Score: 0.246
  3. Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma. Ann Surg Oncol. 2021 Jun; 28(6):3408-3414.
    View in: PubMed
    Score: 0.232
  4. Octogenarians present with a less aggressive phenotype of colon adenocarcinoma. Surgery. 2020 12; 168(6):1138-1143.
    View in: PubMed
    Score: 0.231
  5. Ten-year survival after pathologic complete response in rectal adenocarcinoma. J Surg Oncol. 2021 Jan; 123(1):293-298.
    View in: PubMed
    Score: 0.231
  6. Adjuvant Chemotherapy Benefits on Patients with Extramural Vascular Invasion in Stages II and III Colon Cancer. J Gastrointest Surg. 2021 08; 25(8):2019-2025.
    View in: PubMed
    Score: 0.231
  7. Zip Code-Related Income Disparities in Patients with Colorectal Cancer. Am Surg. 2021 Jun 08; 31348211023435.
    View in: PubMed
    Score: 0.061
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.